Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

168 in total

1. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.

Authors: Ji-Qun Geng; Xiao-Chen Wang; Long-Fei Li; Jun Zhao; Song Wu; Gui-Ping Yu; Kou-Jun Zhu
Journal: Tumour Biol Date: 2015-09-10

Review 2. A review of clinical practice guidelines for lung cancer.

Authors: Jutta J von Dincklage; David Ball; Gerard A Silvestri
Journal: J Thorac Dis Date: 2013-10 Impact factor: 2.895

3. Overexpression of microRNA-936 suppresses non-small cell lung cancer cell proliferation and invasion via targeting E2F2.

Authors: Xiao Zhou; Hui Tao
Journal: Exp Ther Med Date: 2018-07-20 Impact factor: 2.447

Review 4. Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?

Authors: Alfredo Tartarone; Rosa Lerose; Chiara Lazzari; Vanesa Gregorc; Michele Aieta
Journal: Med Oncol Date: 2014-06-24 Impact factor: 3.064

5. Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutations.

Authors: Blanca D López-Ayllón; Javier de Castro-Carpeño; Carlos Rodriguez; Olga Pernía; Inmaculada Ibañez de Cáceres; Cristobal Belda-Iniesta; Rosario Perona; Leandro Sastre
Journal: Int J Clin Exp Pathol Date: 2015-03-01

6. Relationship between uptake of a radioiodinated quinazoline derivative and radiosensitivity in non-small cell lung cancer.

Authors: Hui-Jun Zhu; Mikako Ogawa; Yasuhiro Magata; Masahiko Hirata; Yoshiro Ohmomo; Harumi Sakahara
Journal: Am J Nucl Med Mol Imaging Date: 2014-06-07

Review 7. Tailored therapy in lung cancer.

Authors: George Rakovich; Lise Tremblay
Journal: Can Respir J Date: 2013 Sep-Oct Impact factor: 2.409

Review 8. Surgical management of oligometastatic non-small cell lung cancer.

Authors: Nuria M Novoa; Gonzalo Varela; Marcelo F Jiménez
Journal: J Thorac Dis Date: 2016-11 Impact factor: 2.895

9. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.

Authors: Xiangxian Zhang; Xiao Yang; Junling Wang; Tiansong Liang; Yue Gu; Daoke Yang
Journal: Int J Clin Exp Pathol Date: 2015-09-01

10. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.

Authors: Cigdem Usul Afsar; Berksoy Sahin; Meral Gunaldi; Emine Kılıc Bagir; Derya Gumurdulu; Refik Burgut; Melek Erkisi; Ismail Oguz Kara; Semra Paydas; Feryal Karaca; Vehbi Ercolak
Journal: Int J Clin Exp Pathol Date: 2015-09-01